BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop ...

Holdings announced the date of effectiveness and the ratio of a forthcoming reverse stock split of the Company’s Common Stock. On January 13, 2025, the Company announced, on a Current Report on Form 8 ...

BioXcel Therapeutics (BTAI) announced that it will effect a 1-for-16 reverse stock split of its common stock. The reverse stock split will ...

(RTTNews) - BioXcel Therapeutics, Inc. (BTAI), Thursday announced a reverse stock split of 1-for-16 to regain compliance with the minimum bid price requirement for continued listing on the Nasdaq ...

Mullen Automotive Inc. (NASDAQ:MULN), a player in the motor vehicles and passenger car bodies industry, conducted a Special Meeting of Stockholders where key decisions were made regarding the ...

Al-Baha Investment and Development Co.said its post-reverse stock split share capital will be 218.30 million, instead of 2.18 ...

BioXcel Therapeutics, Inc. (NASDAQ:BTAI), a pharmaceutical company with a market capitalization of $14.83 million, announced today the implementation of a 1-for-16 reverse stock split of its common ...

Plc (NASDAQ:TCBP – Free Report) are set to reverse split on Monday, February 10th. The 1-20 reverse split was announced on Wednesday, February 5th. The number of shares owned by shareholders will be ...

Bakkt stock price surged on speculation of a buyout by Trump's DJT. Check out why I downgraded my Hold rating on BKKT stock ...

Nexxen International reiterated the timeline and process for its upcoming stock exchange and trading structure changes on ...

Universe Pharmaceuticals INC (the "Company") (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company ...

Wexford-based biopharmaceutical company Coeptis announced that it had closed on a $5.7 million addition to its preferred ...